Accuray Seeks Broader Use Of CyberKnife As Credit Crunch Hurts Growth
This article was originally published in The Gray Sheet
Executive Summary
Robotic radiosurgical system maker Accuray is continuing to collect data to support broader use of its CyberKnife system for cancer treatments even as it lowers 2008 revenue expectations citing a credit crunch for some U.S. purchasers